The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Small-molecule correctors of defective F508-CFTR cellular processing identified by high-throughput screening
Open accessAbstract
The most common cause of cystic fibrosis (CF) is deletion of phenylalanine 508 (DeltaF508) in the CF transmembrane conductance regulator (CFTR) chloride channel. The DeltaF508 mutation produces defects in folding, stability, and channel gating. To identify small-molecule correctors of defective cellular processing, we assayed iodide flux in DeltaF508-CFTR-transfected epithelial cells using a fluorescent halide indicator. Screening of 150,000 chemically diverse compounds and more than 1,500 analogs of active compounds yielded several classes of DeltaF508-CFTR correctors (aminoarylthiazoles, quinazolinylaminopyrimidinones, and bisaminomethylbithiazoles) with micromolar potency that produced greater apical membrane chloride current than did low-temperature rescue. Correction was seen within 3-6 hours and persisted for more than 12 hours after washout. Functional correction was correlated with plasma membrane expression of complex-glycosylated DeltaF508-CFTR protein. Biochemical studies suggested a mechanism of action involving improved DeltaF508-CFTR folding at the ER and stability at the cell surface. The bisaminomethylbithiazoles corrected DeltaF508-CFTR in DeltaF508/DeltaF508 human bronchial epithelia but did not correct a different temperature-sensitive CFTR mutant (P574H-CFTR) or a dopamine receptor mutant. Small-molecule correctors may be useful in the treatment of CF caused by the DeltaF508 mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Kozutsumi, Y., Segal, M., Normington, K., Gething, M.-J., & Sambrook, J. (1988) · Nature · doi:10.1038/332462a0 · Cited by 1,321
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., & Welsh, M. J. (1992) · Nature · doi:10.1038/358761a0 · Cited by 1,234
Bobadilla, J. L., Macek, M., Fine, J. P., & Farrell, P. M. (2002) · Human Mutation · doi:10.1002/humu.10041 · Cited by 1,032
Structure and Function of the CFTR Chloride Channel
SHEPPARD, D. N., & WELSH, M. J. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s23 · Cited by 1,018
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Therapeutic approaches to protein-misfolding diseases
Cohen, F. E., & Kelly, J. W. (2003) · Nature · doi:10.1038/nature02265 · Cited by 800
Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation
Dalemans, W., Barbry, P., Champigny, G., Jallat, S., Jallat, S., Dott, K., Dreyer, D., Crystal, R. G., Pavirani, A., Lecocq, J.-P., et al. (1991) · Nature · doi:10.1038/354526a0 · Cited by 707
Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216112 · Cited by 536
Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation
Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J., & Kopito, R. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.635 · Cited by 519
Chloride Conductance Expressed by ΔF508 and Other Mutant CFTRs In Xenopus Oocytes
Drumm, M. L., Wilkinson, D. J., Smit, L. S., Worrell, R. T., Strong, T. V., Frizzell, R. A., Dawson, D. C., & Collins, F. S. (1991) · Science · doi:10.1126/science.1722350 · Cited by 496
Ward, C. L., & Kopito, R. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47306-1 · Cited by 486
Role of CFTR in Airway Disease
PILEWSKI, J. M., & FRIZZELL, R. A. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s215 · Cited by 447
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis
Johnson, L. G., Olsen, J. C., Sarkadi, B., Moore, K. L., Swanstrom, R., & Boucher, R. C. (1992) · Nature Genetics · doi:10.1038/ng0992-21 · Cited by 439
Biosynthesis and Degradation of CFTR
KOPITO, R. R. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s167 · Cited by 410
Lukacs, G. L., Mohamed, A., Kartner, N., Chang, X. B., Riordan, J. R., & Grinstein, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06954.x · Cited by 396
Rubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Green fluorescent protein‐based halide indicators with improved chloride and iodide affinities
Galietta, L. J. V., Haggie, P. M., & Verkman, A. S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02561-3 · Cited by 371
Du, K., Sharma, M., & Lukacs, G. L. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb882 · Cited by 356
Self-citationMisfolding diverts CFTR from recycling to degradation
Sharma, M., Pampinella, F., Nemes, C., Benharouga, M., So, J., Du, K., Bache, K. G., Papsin, B., Zerangue, N., Stenmark, H., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312018 · Cited by 329
Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors
Muanprasat, C., Sonawane, N. D., Salinas, D., Taddei, A., Galietta, L. J. V., & Verkman, A. S. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200409059 · Cited by 264
Gregory, R. J., Rich, D. P., Cheng, S. H., Souza, D. W., Paul, S., Manavalan, P., Anderson, M. P., Welsh, M. J., & Smith, A. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.3886 · Cited by 250
Galietta, L. J. V., Springsteel, M. F., Eda, M., Niedzinski, E. J., By, K., Haddadin, M. J., Kurth, M. J., Nantz, M. H., & Verkman, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101892200 · Cited by 216
Gentzsch, M., Chang, X.-B., Cui, L., Wu, Y., Ozols, V. V., Choudhury, A., Pagano, R. E., & Riordan, J. R. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0176 · Cited by 212
Sharma, M., Benharouga, M., Hu, W., & Lukacs, G. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009172200 · Cited by 211
Genistein potentiates wild-type and delta F508-CFTR channel activity
Hwang, T. C., Wang, F., Yang, I. C., & Reenstra, W. W. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.3.c988 · Cited by 204
Nanomolar Affinity Small Molecule Correctors of Defective ΔF508-CFTR Chloride Channel Gating
Yang, H., Shelat, A. A., Guy, R. K., Gopinath, V. S., Ma, T., Du, K., Lukacs, G. L., Taddei, A., Folli, C., Pedemonte, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303098200 · Cited by 202
Self-citationMa, T., Vetrivel, L., Yang, H., Pedemonte, N., Zegarra-Moran, O., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205932200 · Cited by 175
Self-citationPedemonte, N., Sonawane, N. D., Taddei, A., Hu, J., Zegarra‐Moran, O., Suen, Y. F., Robins, L. I., Dicus, C. W., Willenbring, D., Nantz, M. H., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.010959 · Cited by 146
Self-citationDelta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines
Haws, C. M., Nepomuceno, I. B., Krouse, M. E., Wakelee, H. A., Law, T. C., Xia, Y., Nguyen, H., & Wine, J. J. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1544 · Cited by 138
Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216112 · Cited by 128
Molecular pharmacology of the CFTR Cl− channel
Hwang, T., & Sheppard, D. N. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01386-3 · Cited by 127
Folding Efficiency Is Rate-limiting in Dopamine D4 Receptor Biogenesis
Van Craenenbroeck, K., Clark, S. D., Cox, M. J., Oak, J. N., Liu, F., & Van Tol, H. H. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414043200 · Cited by 107
Chen, E. Y., Bartlett, M. C., Loo, T. W., & Clarke, D. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407887200 · Cited by 99
Al‐Nakkash, L., & Hwang, T. (1999) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050817 · Cited by 66
Galietta, L. J. V., Musante, L., Romio, L., Caruso, U., Fantasia, A. R., Gazzolo, A., Romano, L., Sacco, O., Rossi, G., Varesio, L., et al. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.5.l917 · Cited by 51
Cited by
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A., Joubran, J., Hazlewood, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904709106 · Cited by 1,228
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., & Balch, W. E. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.114844 · Cited by 1,149
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Dekkers, J. F., Wiegerinck, C. L., de Jonge, H. R., Bronsveld, I., Janssens, H. M., de Winter-de Groot, K. M., Brandsma, A. M., de Jong, N. W. M., Bijvelds, M. J. C., Scholte, B. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3201 · Cited by 999
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Metadata
- Authors
- Pedemonte, N.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-08-25
- Volume
- 115
- Issue
- 9
- Pages
- 2564-2571
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1976507289
- Cited by
- 538
- References
- 37
- FWCI
- 23.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.